ArticleNaunyn-Schmiedeberg's archives of pharmacology2019

Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity.

Sameh Saber et al.PubMed ↗Publisher ↗

No numbers read from the abstract.